STAAR Surgical to Present at the BMO Capital Markets Focus on Healthcare Conference

MONROVIA, Calif., Nov. 29 STAAR Surgical Company(Nasdaq: STAA), a leading developer, manufacturer and marketer of minimallyinvasive ophthalmic products, today announced that it will present at the BMOCapital Markets 2007 Focus on Healthcare Conference on Tuesday,December 4, 2007 at the Millennium Broadway Hotel in New York City. Barry G.Caldwell, STAAR Surgical's Chief Executive Officer, will discuss the Company'sbusiness strategy and historical financial performance at 2:00 p.m. EasternTime.

Attendance at the conference is by invitation only. A live audio webcastof STAAR's presentation may be accessed through the Company's website athttp://www.staar.com. An archived replay of the presentation will be availableafter the live presentation and can also be accessed at http://www.staar.com.

About STAAR Surgical

STAAR is a leader in the development, manufacture and marketing ofminimally invasive ophthalmic products employing proprietary technologies.STAAR's products are used by ophthalmic surgeons and include the VisianICL(TM), a tiny, flexible lens implanted to correct refractive errors, as wellas innovative products designed to improve patient outcomes for cataracts andglaucoma. Manufactured in Switzerland by STAAR, the ICL is approved by the FDAfor use in treating myopia, has received CE Marking and is sold in more than40 countries. More than 85,000 ICLs have been sold worldwide. More informationis available at http://www.staar.com.CONTACT: Investors EVC Group Douglas Sherk/ Donald Takaya, 415-896-6820 Media EVC Group Steve DiMattia, 646-201-5445

SOURCE STAAR Surgical

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...